SCHEMBL3846261

SCHEMBL3846261

Cc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncnc(-c4ccc(S(C)(=O)=O)s4)c3c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.34
CA1 P00915 3/20 0.34
CA2 P00918 3/20 0.34
CA9 Q16790 3/20 0.34
KIT P10721 4/20 0.33
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
MTOR P42345 1/20 0.31
PIK3CG P48736 1/20 0.31
AKT1 P31749 1/20 0.31
CD38 P28907 2/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3853047 0.93 CA12 (0.32) CA12CA1CA2CA9PIK3CD
SCHEMBL3854489 0.93 PTGS2 (0.35) CA12CA1CA2CA9KIT
SCHEMBL3854275 0.92 CYP3A4 (0.33) CA12CA1CA2CA9KIT
SCHEMBL3845263 0.91 CYP1A2 (0.34) CA12CA1CA2CA9PIK3CD
SCHEMBL3851760 0.91 MAP4K4 (0.33) CA12CA1CA2CA9KIT
SCHEMBL3847026 0.91 STK17B (0.32) CA12CA1CA2CA9
SCHEMBL3848501 0.91 CA12 (0.35) CA12CA1CA2CA9KIT
SCHEMBL4714668 0.91 AURKA (0.35) CA12CA1CA2CA9KIT
SCHEMBL3849245 0.91 MAP4K4 (0.33) CA12CA1CA2CA9AKT1
SCHEMBL3855222 0.89 CYP1A2 (0.34) KDM4EALDH1A1MAPTHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed